The effects of intramuscular administration of scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled trial

INTRODUCTION: Major depressive disorder (MDD) is a common affective disorder. Currently established pharmacotherapies lack rapid clinical response, thereby limiting their ability to bring instant relief to patients. A series of clinical trials has demonstrated the antidepressant effects of scopolami...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jingjing, Yang, Jian, Zhu, Xuequan, Zghoul, Tarek, Feng, Lei, Chen, Runsen, Wang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331769/
https://www.ncbi.nlm.nih.gov/pubmed/32655854
http://dx.doi.org/10.1177/2045125320938556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331769/
https://www.ncbi.nlm.nih.gov/pubmed/32655854
http://dx.doi.org/10.1177/2045125320938556

Ejemplares similares